Cargando…
GPR110 (ADGRF1) mediates anti-inflammatory effects of N-docosahexaenoylethanolamine
BACKGROUND: Neuroinflammation is a widely accepted underlying condition for various pathological processes in the brain. In a recent study, synaptamide, an endogenous metabolite derived from docosahexaenoic acid (DHA, 22:6n-3), was identified as a specific ligand to orphan adhesion G-protein-coupled...
Autores principales: | Park, Taeyeop, Chen, Huazhen, Kim, Hee-Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858791/ https://www.ncbi.nlm.nih.gov/pubmed/31730008 http://dx.doi.org/10.1186/s12974-019-1621-2 |
Ejemplares similares
-
Orphan GPR110 (ADGRF1) targeted by N-docosahexaenoylethanolamine in development of neurons and cognitive function
por: Lee, Ji-Won, et al.
Publicado: (2016) -
Exacerbating effects of single-dose acute ethanol exposure on neuroinflammation and amelioration by GPR110 (ADGRF1) activation
por: Banerjee, Sharmistha, et al.
Publicado: (2023) -
N-Docosahexaenoylethanolamine ameliorates LPS-induced neuroinflammation via cAMP/PKA-dependent signaling
por: Park, Taeyeop, et al.
Publicado: (2016) -
Interaction between GPR110 (ADGRF1) and tight junction protein occludin implicated in blood-brain barrier permeability
por: Huang, Bill X., et al.
Publicado: (2023) -
Synaptamide activates the adhesion GPCR GPR110 (ADGRF1) through GAIN domain binding
por: Huang, Bill X., et al.
Publicado: (2020)